指南与共识术前评估与围术期医学

围术期质量改进共识:择期手术后血压、风险与结局

Perioperative Quality Initiative consensus statement on postoperative blood pressure, risk and outcomes for elective surgery.
指南 / 共识 · Br J Anaesth · 2019-03-02

该共识由POQI 3工作组采用改良德尔菲法制定,针对成人非心脏手术术后非ICU患者,基于MEDLINE文献评估术后血压监测、管理与结局。共识推荐:术后收缩压<90 mm Hg与损害相关;术前高血压患者损害阈值可能更高;术后高血压损害阈值证据不足;更频繁测压可早期识别风险;术后停用β受体阻滞剂、ARB和ACEI有损害证据。

要点

  • 术后收缩压<90 mm Hg与损害相关,需关注。
  • 术前高血压患者损害阈值可能高于90 mm Hg。
  • 术后停用β受体阻滞剂、ARB、ACEI有损害证据。

核心结论

  • 术后低血压或高血压与不良结局相关,但最佳干预水平、测压方法时机及长期降压药管理仍需研究。

研究设计与样本

  • 采用改良德尔菲技术,评估MEDLINE中关于术后血压监测、管理和结局的论文,制定实践推荐。

主要发现

  • 术后收缩压<90 mm Hg有损害证据;术前高血压患者损害阈值可能更高;术后高血压损害阈值证据不足;更频繁测压可能更早识别风险;术后停用β受体阻滞剂、ARB和ACEI有损害证据。

关键数值与推荐

  • 术后收缩压<90 mm Hg与损害相关;术前高血压患者损害阈值可能高于90 mm Hg;术后高血压损害阈值证据不足;更频繁测压可能早期识别风险;术后停用β受体阻滞剂、ARB和ACEI有损害证据。

临床怎么用

  • 术后应监测血压,避免收缩压<90 mm Hg,尤其术前高血压患者注意个体化阈值;不应随意停用β受体阻滞剂、ARB和ACEI。

局限性

  • 证据多来自观察性研究,缺乏精确阈值;需进一步研究最佳测压方法、时机及长期降压药管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative hypotension and hypertension are frequent events associated with increased risk of adverse outcomes. However, proper assessment and management is often poorly understood. As a part of the PeriOperative Quality Improvement (POQI) 3 workgroup meeting, we developed a consensus document addressing this topic. The target population includes adult, non-cardiac surgical patients in the postoperative phase outside of the ICU. METHODS: A modified Delphi technique was used, evaluating papers published in MEDLINE examining postoperative blood pressure monitoring, management, and outcomes. Practice recommendations were developed in line with National Institute for Health and Care Excellence guidelines. RESULTS: Consensus recommendations were that (i) there is evidence of harm associated with postoperative systolic arterial pressure <90 mm Hg; (ii) for patients with preoperative hypertension, the threshold at which harm occurs may be higher than a systolic arterial pressure of 90 mm Hg; (iii) there is insufficient evidence to precisely define the level of postoperative hypertension above which harm will occur; (iv) a greater frequency of postoperative blood pressure measurement is likely to identify risk of harm and clinical deterioration earlier; and (v) there is evidence of harm from withholding beta-blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors in the postoperative period. CONCLUSIONS: Despite evidence of associations with postoperative hypotension or hypertension with worse postoperative outcome, further research is needed to define the optimal levels at which intervention is beneficial, to identify the best methods and timing of postoperative blood pressure measurement, and to refine the management of long-term antihypertensive treatment in the postoperative phase.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. McEvoy MD, Gupta R, Koepke EJ, et al. Perioperative Quality Initiative consensus statement on postoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth. 2019. PMID: 30916008. doi:10.1016/j.bja.2019.01.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。